Skip Navigation


International Immunology Advance Access originally published online on November 15, 2005
International Immunology 2005 17(12):1619-1629; doi:10.1093/intimm/dxh342
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/12/1619    most recent
dxh342v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oki, S.
Right arrow Articles by Miyake, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oki, S.
Right arrow Articles by Miyake, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Preferential Th2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo

Shinji Oki, Chiharu Tomi, Takashi Yamamura and Sachiko Miyake

Department of Immunology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan

Correspondence to: S. Miyake; E-mail: miyake{at}ncnp.go.jp

The altered glycolipid ligand OCH is a selective inducer of Th2 cytokines from NKT cells and a potent therapeutic reagent for Th1-mediated autoimmune diseases. Although we have previously shown the intrinsic molecular mechanism of preferential IL-4 production by OCH-stimulated NKT cells, little is known about the extrinsic regulatory network for IFN-{gamma} production. Here we demonstrate that OCH induces lower production of IFN-{gamma}, not only by NKT cells but also by NK cells compared with {alpha}-galactosylceramide. OCH induced lower IL-12 production due to ineffective primary IFN-{gamma} and CD40 ligand expression by NKT cells, and resulted in lower secondary IFN-{gamma} induction. Co-injection of a sub-optimal dose of IFN-{gamma} and stimulatory anti-CD40 mAb compensates for the lower induction of IL-12 by OCH administration. IL-12 converts OCH-induced cytokine expression from IL-4 predominance to IFN-{gamma} predominance. Furthermore, CpG oligodeoxynucleotide augmented IL-12 production when co-administrated with OCH, resulting in increased IFN-{gamma} production. Taken together, the lower IL-12 production and subsequent lack of secondary IFN-{gamma} burst support the effective Th2 polarization of T cells by OCH. In addition, highlighted in this study is the characteristic property of OCH that can induce the differential production of IFN-{gamma} or IL-4 according to the availability of IL-12.

Keywords: cell activation, cytokines, inflammation, natural killer, rodent, T cells

Transmitting editor: K. Okumura


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. Ambrosino, M. Terabe, R. C. Halder, J. Peng, S. Takaku, S. Miyake, T. Yamamura, V. Kumar, and J. A. Berzofsky
Cross-Regulation between Type I and Type II NKT Cells in Regulating Tumor Immunity: A New Immunoregulatory Axis
J. Immunol., October 15, 2007; 179(8): 5126 - 5136.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Forestier, T. Takaki, A. Molano, J. S. Im, I. Baine, E. S. Jerud, P. Illarionov, R. Ndonye, A. R. Howell, P. Santamaria, et al.
Improved Outcomes in NOD Mice Treated with a Novel Th2 Cytokine-Biasing NKT Cell Activator
J. Immunol., February 1, 2007; 178(3): 1415 - 1425.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.